They identified a new lncRNA, called ADAMTS9-AS1, which was downregulated in CRC tissues, while the data retrieved from the TCGA demonstrated that it was significantly associated with clinical outcomes. This evidence concerns the gene ADAMTS9 and colorectal carcinoma.